A new perspective in cancer immunotherapy: PD-1 on myeloid cells takes center stage in orchestrating immune checkpoint blockade

See allHide authors and affiliations

Science Immunology  03 Jan 2020:
Vol. 5, Issue 43, eaaz8128
DOI: 10.1126/sciimmunol.aaz8128

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution


PD-1 mediates antitumor immunity by regulating lineage fate commitment and function of myeloid cells (see the related Research Article by Strauss et al.).

View Full Text

Stay Connected to Science Immunology

Editor's Blog